Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Eli Lilly and Company
Lebanese University
OHSU Knight Cancer Institute
University Medical Center Groningen
Emory University
University of California, San Francisco